Based on our results it seems that chymase does not play any significant role in the developmental phase of hypertension, since no blood pressure or any other change was observed after chymase inhibition (similarly after chymostatin and rapeseed-derived peptides). This evidence concerns the gene CMA1 and hypertensive disorder.